GlassScriptPhysician profile
Anna Maizlin
NPI 1639594864
$5,943.10
in general payments reported to CMS, 2019-2025
32 companies · $2,411 in 2025
The $2,411 reported for 2025 was more than what 95% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $1,074 · 2023: $698 · 2024: $1,550 · 2025: $2,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,269 · Travel and Lodging: $1,345 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.76 |
| Travel and Lodging | $1,344.55 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $1,908.97 | 2024-2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $726.04 | 2021-2025 | Relistor |
| Nevro Corp. | $650.80 | 2022-2024 | Senza |
| Abbvie INC. | $477.90 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $393.55 | 2022-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $278.33 | 2022-2025 | Synchromedii, Inceptiv |
| Scilex Pharmaceuticals INC. | $165.57 | 2021-2025 | Ztlido |
| Nalu Medical, INC. | $156.04 | 2022-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $154.85 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $119.25 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Amgen INC. | $113.75 | 2024 | Repatha |
| Spr Therapeutics, INC | $89.79 | 2023-2025 | Sprint Pns System |
| Protega Pharmaceutials INC | $83.00 | 2024-2025 | Roxybond |
| Tersera Therapeutics LLC | $71.56 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $69.32 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $54.56 | 2022 | |
| Abbott Laboratories | $52.95 | 2024 | Proclaim |
| Averitas Pharma INC. | $43.16 | 2023 | Qutenza |
| Alnylam Pharmaceuticals INC. | $41.34 | 2024 | Amvuttra |
| Curonix LLC | $40.79 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $29.75 | 2023 | Zilretta, Iovera |
| Ibsa Pharma INC. | $28.85 | 2021-2023 | Tirosint, Licart |
| Fidia Pharma USA INC. | $26.59 | 2025 | Hymhyn |
| Si-Bone, INC. | $24.69 | 2024 | |
| Arbor Pharmaceuticals, INC. | $24.62 | 2021 | |
| Globus Medical, INC. | $22.94 | 2025 | Senza |
| Ani Pharmaceuticals, INC. | $20.19 | 2025 | Purified Cortrophin Gel |
| Pfizer INC. | $16.38 | 2021 | |
| Lundbeck LLC | $16.26 | 2022 | |
| Tonix Medicines, INC. | $14.13 | 2025 | Tonmya |
| Bioventus LLC | $13.79 | 2025 | Xcell |
| Biodelivery Sciences International, INC. | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Maizlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.